Guiling Li
Impact in
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Antibiotic Resistance in Bacteria 6
- Curcumin's Biomedical Applications 5
-
- MicroRNA in disease regulation 12
- Co-authors
- Kai‐Fu Tang (12 shared papers)Miriam L. Greenberg (5 shared papers)Jingwen Liu (16 shared papers)Xinru Li (7 shared papers)Jian Li (14 shared papers)Xinyou Xie (8 shared papers)YiJiang Song (8 shared papers)Yanzhong Wang (5 shared papers)
- Journals
- PLoS ONE (5 papers)Journal of Biological Chemistry (4 papers)Carcinogenesis (4 papers)Annals of Oncology (3 papers)Food Bioscience (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Guiling Li
119 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 123
- Pharmaceutical Science 177
- Geriatrics and Gerontology 87
- Cancer Research 267
- Molecular Biology 1.0k
- Molecular Medicine 64
Countries citing papers authored by Guiling Li
This map shows the geographic impact of Guiling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiling Li more than expected).
Fields of papers citing papers by Guiling Li
This network shows the impact of papers produced by Guiling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiling Li. The network helps show where Guiling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Guiling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 133 | |
| 2 | 2011 | 130 | |
| 3 | 2012 | 128 | |
| 4 | 2014 | 69 | |
| 5 | 2015 | 60 | |
| 6 | 2016 | 59 | |
| 7 | 2014 | 58 | |
| 8 | 2016 | 56 | |
| 9 | 2006 | 53 | |
| 10 | 2021 | 52 | |
| 11 | 2015 | 51 | |
| 12 | 2013 | 51 | |
| 13 | 2013 | 47 | |
| 14 | 2019 | 45 | |
| 15 | 2019 | 43 | |
| 16 | 2022 | 41 | |
| 17 | 2013 | 41 | |
| 18 | 2025 | 40 | |
| 19 | 2013 | 40 | |
| 20 | 2007 | 38 |
About Guiling Li
Guiling Li is a scholar working on Molecular Medicine, Cancer Research, Molecular Biology, Pharmacology and Epidemiology, having authored 131 papers that have together received 2.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Mitochondrial Function and Pathology (6 papers), Antibiotic Resistance in Bacteria (6 papers), Bacterial biofilms and quorum sensing (5 papers), Gut microbiota and health (5 papers), Curcumin's Biomedical Applications (5 papers), RNA Interference and Gene Delivery (5 papers) and Bacteriophages and microbial interactions (5 papers). The work is most often cited by research in Pharmaceutical Science (177 citations), Geriatrics and Gerontology (87 citations), Cancer Research (267 citations), Molecular Biology (1.0k citations) and Molecular Medicine (64 citations). Guiling Li has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Kai‐Fu Tang, Miriam L. Greenberg, Jingwen Liu, Xinru Li, Jian Li, Xinyou Xie, YiJiang Song, Yanzhong Wang, Yan Liu and Zhujun Deng. Their work appears in journals such as PLoS ONE, Journal of Biological Chemistry, Carcinogenesis, Annals of Oncology and Food Bioscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.